Hexylresorcinol
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Hexylresorcinol
Description:
Hexylresorcinol (4-Hexylresorcinol) is a natural compound found in plants with antimicrobial, anthelmintic, antiseptic and antitumor activities. Hexylresorcinol can induce apoptosis in squamous carcinoma cells. Hexylresorcinol is a reversible and noncompetitive inhibitor of α-glucosidase. Hexylresorcinol has protective effects against oxidative DNA damage[1][2][3][4][5].Product Name Alternative:
4-HexylresorcinolUNSPSC:
12352005Hazard Statement:
H302, H319, H411Target:
Apoptosis; Bacterial; Endogenous Metabolite; Glycosidase; ParasiteType:
Reference compoundRelated Pathways:
Anti-infection; Apoptosis; Metabolic Enzyme/ProteaseField of Research:
Cancer; Infection; Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/Hexylresorcinol.htmlConcentration:
10mMPurity:
99.98Solubility:
DMSO : 100 mg/mL (ultrasonic) |Ethanol : 100 mg/mL (ultrasonic)Smiles:
OC1=CC=C(CCCCCC)C(O)=C1Molecular Formula:
C12H18O2Molecular Weight:
194.27Precautions:
H302, H319, H411References & Citations:
[1]Y. A. Nikolaev, et al. The use of 4-Hexylresorcinol as antibiotic adjuvant. PLoS One. 2020; 15 (9) : e0239147.|[2]Seong-Gon Kim, et al. 4-hexylresorcinol exerts antitumor effects via suppression of calcium oscillation and its antitumor effects are inhibited by calcium channel blockers. Oncol Rep. 2013 May;29 (5) :1835-40.|[3]Shuang Song, et al. Inhibitory potential of 4-hexylresorcinol against α-glucosidase and non-enzymatic glycation: Activity and mechanism. J Biosci Bioeng. 2020 Nov 12; S1389-1723 (20) 30400-X.|[4]Gow-Chin Yen, et al. Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocyte. Free Radic Res. 2003 May;37 (5) :509-14.|[5]Min-Keun Kim, et al. 4-Hexylresorcinol induced angiogenesis potential in human endothelial cells. Maxillofac Plast Reconstr Surg. 2020 Dec; 42 (1) : 23.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
LaunchedIsoform:
Human Endogenous MetaboliteCAS Number:
[136-77-6]
